News

• 2025.06.25 news
  Announcement of Nikkei Biotech ONLINE article on the Phase II clinical trial for cutaneous angiosarcoma
• 2025.06.13 news
  Announcement of the Kahoku Shimpo article on seminar by the “Sendai City x Tohoku University Smart Frontier Council Wellness Subcommittee” in relation to the XPRIZE Healthspan, a global longevity competition
• 2025.06.02 news
  Our pharmaceutical products related to anti-aging and longevity medicine were introduced on Mr. Sunday (TV News)
• 2025.05.30 news
  Announcement of a seminar by the “Sendai City x Tohoku University Smart Frontier Council Wellness Subcommittee” in relation to the XPRIZE Healthspan, a global longevity competition
• 2025.05.23 news
  An article about the global longevity competition XPRIZE Healthspan was published in the Science Newspaper
• 2025.05.13 news
  Announcement of media coverages regarding the XPRIZE Healthspan, a global competition for the human longevity
• 2025.02.21 news
  Notice of a newspaper article publication regarding the start of Phase III clinical trial for malignant melanoma with a PAI-1 inhibitor RS5614
• 2025.01.31 news
  A newspaper article about our aging and longevity researches was published
• 2024.10.21 news
  Notice of a special lecture on our PAI-1 inhibitor RS5614 at the 31st Japanese Society of Transfusion Medicine and Cell Therapy
• 2024.10.10 news
  Notice regarding head office relocation